Zurück

In den Warenkorb

Empfehlung per E-Mail versenden

Probeexemplar anfordern

Gerne schicken wir Ihnen ein Probeexemplar an die angegeben Adresse.
Recent Progress In Medicinal Plants (Metabolic Disorders Diabetes, Part-1)

Recent Progress In Medicinal Plants (Metabolic Disorders Diabetes, Part-1)

vonGovil, J. N. | Singh, Surender
Englisch, Erscheinungstermin Juni 2018
lieferbar
626,67 €
(inkl. MwSt.)

Informationen zum Titel

978-1-62699-338-9
Juni 2018
2018
eBook
EPUB mit Adobe DRM
522
Englisch
Diabetes mellitus is known to be a chronic metabolic disorder caused due to an impaired metabolism of glucose and other energy-providing molecules characterized by a slow progression of vascular and neuropathic complications. The present volume reviews the elucidation of several bioactive extracts from 25 potential medicinal plants (largely used in traditional medicine) and their mechanism of action in treatment of diabetes. These 25 herbs have been proved for its anti-diabetic potential using in vitro and in vivo model systems. Several strategies have been used in the management and treatment of diabetes. These strategies are targeted towards increasing endogenous insulin availability (sulfonylureas) enhancing insulin sensitivity and inhibiting ?-glucosidase. Experimental evidences presented in core drug have shown and proven that each of these herbs possess bioactive compounds with anti-diabetic properties. In other words, this volume is a comprehensive compilation covering all aspects of Diabetes Management touching from topics like Definition and Etiology, Pathophysiology to adversities and toxicology, from pharmacological management to herbal drug delivery through Nanotechnology, from insights into the plant insulin to insights into the management of metabolic disorders in pharmacology. Hence, the information is presented in two parts. Diabetes I provide information on the wide range of basic components that are necessary for the management of Diabetes. Besides, the review of seven plants namely, Adhatoda vasica, Aegle marmelos, Andrographis paniculata, Allium sativum, Annona squamosa, Azadirachta indica and Carissa edulis, serves as a compilation of details in the isolation of pure compounds in relation to antidiabetic effects and their potential mode of action. In the second part i.e. Diabetes II, eighteen plants presented are Cinnamon, Coccinia indica, Eucalyptus globulus, Eugenia jambos, Ficus glomerata, Gymnema sylvestris, Ipomea batotos, Medicago sativa, Momordica charantia, Nelumbo nucifera, Nigella sativa, Pongamia pinnata, Swertia chirayita, Syzygium malaccense, Tinospora cordifolia, Trigonella foenum-graceum, Vinca rosea, Withania somnifera. Both the volumes have been presented in a manner that is simple and easy to understand where a balance between theory and practical inputs has been struck. The contributions are from far and wide including Canada, Ethiopia India, KSA, Malaysia, Mauritius, Nigeria, Pakistan, Romania, Spain, and USA. The volume is aimed at a wide range of audience of ethno botanists, phytochemists, pharmacologists, pharmacists, pharmacognosists and other research scientists engaged in the search of new drugs from natural resources for Diabetes Mellitus treatment.
Kundenmitteilung
EU-Datenschutzgrundverordnung

Die DSGVO stärkt die Datenschutzrechte europaweit für uns alle. Bei vub haben wir aus diesem Anlass unsere Datenschutzerklärung grundlegend verändert:

  • Wir stellen noch übersichtlicher dar, wie und wofür wir personenbezogene Daten verarbeiten (wenn überhaupt, denn das Verwerten Ihrer persönlichen Daten ist überhaupt nicht unser Geschäft!).
  • Wir informieren in unserer neuen Datenschutzerklärung über die Kundenrechte.
  • Wir haben die Datenschutzerklärung übersichtlicher gestaltet.
  • Ab dem 25. Mai 2018 können Sie in Ihrem Kundenkonto im Menü unter „mein vub - Einstellungen“ den gewünschten Datenschutz selbst einstellen.

Bei Fragen wenden Sie sich bitte jederzeit an unseren vub-Kundenservice und Ihre bekannten Ansprechpartner unter premiumservice@vub.de.

Bestätigung